Today, Mediclinic International PLC (MDC) Insider Alan Grieve Buys 1,152 Shares

Today, Mediclinic International PLC (MDC) Insider Alan Grieve Buys 1,152 Shares

Mediclinic International PLC (LON:MDC) insider Alan Grieve acquired 1,152 shares of the stock in a transaction on Monday, November 28th. The shares were bought at an average cost of GBX 734 ($9.11) per share, for a total transaction of £8,455.68 ($10,489.62).

Mediclinic International PLC (LON:MDC) opened at 703.00 on Tuesday. Mediclinic International PLC has a 52 week low of GBX 701.95 and a 52 week high of GBX 1,174.00. The stock has a 50 day moving average price of GBX 845.21 and a 200 day moving average price of GBX 949.09. The firm’s market cap is GBX 5.18 billion.

The company also recently disclosed a dividend, which will be paid on Monday, December 12th. Investors of record on Thursday, November 24th will be paid a GBX 3.20 ($0.04) dividend. This represents a yield of 0.41%. The ex-dividend date is Thursday, November 24th.

A number of equities analysts have weighed in on the company. JPMorgan Chase & Co. reissued a “neutral” rating and set a GBX 1,160 ($14.39) price objective on shares of Mediclinic International PLC in a research note on Tuesday, August 23rd. Citigroup Inc. lowered Mediclinic International PLC to a “neutral” rating and set a GBX 1,090 ($13.52) price objective on the stock. in a research note on Monday, September 12th. Jefferies Group lowered their price objective on Mediclinic International PLC from GBX 833 ($10.33) to GBX 812 ($10.07) and set a “hold” rating on the stock in a research note on Wednesday, September 28th. Credit Suisse Group AG lowered their price objective on Mediclinic International PLC from GBX 1,120 ($13.89) to GBX 1,045 ($12.96) and set an “outperform” rating on the stock in a research note on Friday, November 11th. Finally, HSBC lowered their price objective on Mediclinic International PLC from GBX 920 ($11.41) to GBX 745 ($9.24) and set a “reduce” rating on the stock in a research note on Friday, November 11th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of GBX 933.33 ($11.58).

Related posts

Leave a Comment